Effect of statins on breast cancer recurrence and mortality: a review

References

• American Cancer SocietyCancer Facts & Figures 2017AtlantaAmerican Cancer Society2017
   Google Scholar
• BeseNSSutPAOberAThe effect of treatment interruptions in the postoperative irradiation of breast cancerOncology200569321422316127290
   PubMed Web of Science ®Google Scholar
• OhriNRapkinBDGuhaCKalnickiSGargMRadiation therapy noncompliance and clinical outcomes in an urban academic cancer centerInt J Radiat Oncol Biol Phys201695256357027020104
   PubMed Web of Science ®Google Scholar
• HershmanDLShaoTKushiLHEarly discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerBreast Cancer Res Treat2011126252953720803066
   PubMed Web of Science ®Google Scholar
• McCowanCShearerJDonnanPTCohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancerBr J Cancer200899111763176818985046
   PubMed Web of Science ®Google Scholar
• GuQPaulose-RamRBurtVKitBPrescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003–2012NCHS Data Brief201417718
   PubMedGoogle Scholar
• LazarLDPletcherMJCoxsonPGBibbins-DomingoKGoldmanLCost-effectiveness of statin therapy for primary prevention in a low-cost statin eraCirculation2011124214615321709063
   PubMed Web of Science ®Google Scholar
• MachFToward a role for statins in immunomodulationMol Interv20022847848014993398
   PubMedGoogle Scholar
• MulhauptFMatterCMKwakBRStatins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cellsCardiovasc Res200359375576614499877
   PubMed Web of Science ®Google Scholar
• BellostaSFerriNBerniniFPaolettiRCorsiniANon-lipid-related effects of statinsAnn Med200032316417610821323
   PubMed Web of Science ®Google Scholar
• HessDCFaganSCPharmacology and clinical experience with simvastatinExpert Opin Pharmacother20012115316311336576
   PubMedGoogle Scholar
• KwanMLHabelLAFlickEDQuesenberryCPCaanBPost-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivorsBreast Cancer Res Treat2008109357357917674197
   PubMed Web of Science ®Google Scholar
• AhernTPPedersenLTarpMStatin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort studyJ Natl Cancer Inst2011103191461146821813413
   PubMed Web of Science ®Google Scholar
• ManthravadiSShresthaAMadhusudhanaSImpact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysisInt J Cancer201613961281128827176735
   PubMed Web of Science ®Google Scholar
• ChaeYKValsecchiMEKimJReduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statinsCancer Invest201129958559321936625
   PubMed Web of Science ®Google Scholar
• BoudreauDMYuOChubakJComparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancerBreast Cancer Res Treat2014144240541624557337
   PubMed Web of Science ®Google Scholar
• SakellakisMAkinosoglouKKostakiASpyropoulouDKoutrasAStatins and risk of breast cancer recurrenceBreast Cancer2016819920527853392
   PubMedGoogle Scholar
• BrewerTMMasudaHLiuDDStatin use in primary inflammatory breast cancer: a cohort studyBr J Cancer2013109231832423820253
   PubMed Web of Science ®Google Scholar
• MurtolaTJVisvanathanKArtamaMVainioHPukkalaEStatin use and breast cancer survival: a nationwide cohort study from FinlandPLoS One2014910e11023125329299
   PubMed Web of Science ®Google Scholar
• CardwellCRHicksBMHughesCMurrayLJStatin use after diagnosis of breast cancer and survival: a population-based cohort studyEpidemiology2015261687825304447
   PubMed Web of Science ®Google Scholar
• ZhongSZhangXChenLMaTTangJZhaoJStatin use and mortality in cancer patients: systematic review and meta-analysis of observational studiesCancer Treat Rev201541655456725890842
   PubMed Web of Science ®Google Scholar
• Mc MenaminÚCMurrayLJHughesCMCardwellCRStatin use and breast cancer survival: a nationwide cohort study in ScotlandBMC Cancer201616160027491389
   PubMed Web of Science ®Google Scholar
• BonovasSFilioussiKTsavarisNSitarasNMUse of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studiesJ Clin Oncol200523348606861216260694
   PubMed Web of Science ®Google Scholar
• UndelaKSrikanthVBansalDStatin use and risk of breast cancer: a meta-analysis of observational studiesBreast Cancer Res Treat2012135126126922806241
   PubMed Web of Science ®Google Scholar
• DaleKMColemanCIHenyanNNKlugerJWhiteCMStatins and cancer risk: a meta-analysisJAMA20062951748016391219
   PubMed Web of Science ®Google Scholar
• BrowningDRLMartinRMStatins and risk of cancer: a systematic review and metaanalysisInt J Cancer2007120483384317131313
   PubMed Web of Science ®Google Scholar
• KuoppalaJLamminpääAPukkalaEStatins and cancer: a systematic review and meta-analysisEur J Cancer200844152122213218707867
   PubMed Web of Science ®Google Scholar
• BaigentCKeechAKearneyPMCholesterol Treatment Trialists’ (CTT) CollaboratorsEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet200536694931267127816214597
   PubMed Web of Science ®Google Scholar
• DesaiPLehmanAChlebowskiRTStatins and breast cancer stage and mortality in the Women’s Health InitiativeCancer Causes Control201526452953925736184
   PubMed Web of Science ®Google Scholar
• McDougallJAMaloneKEDalingJRCushing-HaugenKLPorterPLLiCILong-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of ageCancer Epidemiol Biomarkers Prev20132291529153723833125
   PubMed Web of Science ®Google Scholar
• ArunBKGongYLiuDPhase I biomarker modulation study of atorvastatin in women at increased risk for breast cancerBreast Cancer Res Treat20161581677727287781
   PubMed Web of Science ®Google Scholar
• GarwoodERKumarASBaehnerFLFluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancerBreast Cancer Res Treat2010119113714419728082
   PubMed Web of Science ®Google Scholar
• BjarnadottirORomeroQBendahlPOTargeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trialBreast Cancer Res Treat2013138249950823471651
   PubMed Web of Science ®Google Scholar
• KoyuturkMErsozMAltiokNSimvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNKCancer Lett2007250222022817125918
   PubMed Web of Science ®Google Scholar
• BrozovicAFritzGChristmannMLong-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistanceInt J Cancer2004112697498515386344
   PubMed Web of Science ®Google Scholar
• Brantley-FinleyCLyleCSDuLThe JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposideBiochem Pharmacol200366345946912907245
   PubMed Web of Science ®Google Scholar
• DenoyelleCVasseMKörnerMCerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro studyCarcinogenesis20012281139114811470741
   PubMed Web of Science ®Google Scholar
• AlonsoDFarinaHSkiltonGGabriMDe LorenzoMGomezDReduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesisBreast Cancer Res Treat199850183939802623
   PubMed Web of Science ®Google Scholar
• LacerdaLReddyJPLiuDSimvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with post-mastectomy radiationStem Cells Transl Med20143784985624833589
   PubMed Web of Science ®Google Scholar
• AbeOAbeREnomotoKEarly Breast Cancer Trialists’ Collaborative Group (EBCTCG)Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsLancet200536695032087210616360786
   PubMed Web of Science ®Google Scholar
• PanoffJHurleyJTakitaCRisk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiationBreast Cancer Res Treat2011128389990621475999
   PubMed Web of Science ®Google Scholar
• MeyersMOKlauber-DemoreNOllilaDWImpact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancerAnn Surg Oncol201118102851285721442348
   PubMed Web of Science ®Google Scholar
• Charafe-JauffretEGinestierCIovinoFAldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancerClin Cancer Res2010161455520028757
   PubMed Web of Science ®Google Scholar
• RosenthalDTZhangJBaoLRhoC impacts the metastatic potential and abundance of breast cancer stem cellsPLoS One201277e4097922911725
   PubMed Web of Science ®Google Scholar
• XiaoYYeYYearsleyKJonesSBarskySHThe lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotypeAm J Pathol2008173256157418599608
   PubMed Web of Science ®Google Scholar
• OstrauCHülsenbeckJHerzogMLovastatin attenuates ionizing radiation-induced normal tissue damage in vivoRadiother Oncol200992349249919615773
   PubMed Web of Science ®Google Scholar
• WangJBoermaMFuQKulkarniAFinkLMHauer-JensenMSimvastatin ameliorates radiation enteropathy development after localized, fractionated irradiation by a protein C-independent mechanismInt J Radiat Oncol Biol Phys20076851483149017674978
   PubMed Web of Science ®Google Scholar
• HaydontVBourgierCPocardMPravastatin inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in ratsClin Cancer Res200713185331534017875761
   PubMed Web of Science ®Google Scholar